Objective: To describe the burden of pediatric tuberculosis (TB) in a HIV-infected population and explore the demographic and clinical factors associated with the occurrence of pediatric TB.
Introduction
Extensive geographic, biologic, and epidemiologic overlap exists between infections with HIV and tuberculosis (TB) in sub-Saharan Africa. The WHO estimates that one-third of the world's population is infected with Mycobacterium tuberculosis [1] , a condition referred to as latent tuberculosis infection (LTBI). Although the bacterium often remains latent, people with intact immune systems have a lifetime risk for development of active TB of about 5-10% [1] , whereas those infected with HIV have a lifetime risk of approximately 30-40% [2, 3] . TB manifestations are more severe and progression to death is more rapid in HIV-positive patients [4] . In addition, TB can accelerate the course of HIV disease, increasing morbidity, mortality, and the frequency of opportunistic infections [5, 6] .
Childhood TB contributes at least 10-15% to the global burden of this disease [7] . In areas where TB is under good control, the incidence of TB is low among HIVinfected children [8] , whereas the incidence is high where TB control is poor [9, 10] . This may be explained in part by the shifting of the age distribution of TB in HIVendemic areas. In HIV-affected communities, the highest TB incidence rate occurs among men and women in their reproductive years, as opposed to the historical scenario of a higher incidence in elderly men [11] . The higher TB prevalence among parents and other caregivers, and the subsequent higher risk for children to be exposed to M. tuberculosis, help contribute to a higher TB burden for children in HIV-endemic areas.
The diagnosis of childhood TB presents a major challenge. In children, use of the bacteriologic culture, the accepted 'gold standard' [12] , is limited due to the paucibacillary nature of the illness in children [13] , the difficulty in specimen collection among young patients [14] , as well as limited laboratory capacity in resource-constrained environment [15] . Diagnostic problems are even more pronounced in HIV-infected children because the symptoms, disease progression and interpretation of chest radiographs may all be confounded by HIV-related comobidities [16] .
In spite of these obstacles, there is an urgent need for data on the burden of TB and risk factors that could help identify effective interventions. We performed an observational, prospective cohort study of children participating in an HIV treatment program in Tanzania. The objectives of this study were to describe the burden of pediatric TB in an HIV-infected population; and to describe the demographic and clinical factors associated with the occurrence of pediatric TB. 
Methods

Study population
Standard of care
Following enrollment, clinic visits were scheduled monthly for children receiving antiretroviral therapy (ART). For children not receiving ART, visits were scheduled monthly for those aged 5 years of age and below, and at 3-monthly intervals for children above age 5 years. In general, children were screened for tuberculosis based on clinical symptoms, sputum smear (for children 5 years of age or older) or chest X-ray (in younger children). Sputum culture was not available. For HIV-infected children in the program, ART initiation criteria were for children between 12 and 18 months, CD4þ % less than 25; for children between 19 and 59 months, CD4þ % below 20; for children 5 years old and above, CD4þ % below 15 (or CD4 þ cell count <200 cells/ml). For children under 1 year old, the criteria were changed in the year of 2007. Before 2007, for those who were at WHO stage III/IV, ART were initiated regardless of CD4þ %; for those who were at WHO stage I/II, ART were initiated if CD4þ % was less than 25%. After 2007, all children under age 1 year old were initiated on ART regardless of CD4þ % or WHO stage.
Data collection
At each patient visit, physicians and nurses completed standardized forms capturing demographic and clinical information, as well as medications prescribed. Anthropometric measures, including height, weight, and mid upper arm circumference (MUAC), were obtained by nurses using standardized techniques [17] . Blood samples were collected and immunologic, biochemical, and hematologic tests were performed. The data assurance process included several stages of review and editing for checking completeness and consistency, double data entry, supervisory checks of the inconsistencies discovered at second data entry, and finally 'retirement' and archiving of the form.
Study variables
Incident TB cases were defined as children who were prescribed anti-TB medications during follow-up and who were not diagnosed with TB at enrollment or within 30 days after enrollment. Demographic, clinical and nutritional characteristics were considered as independent variables. Z scores were calculated using growth references published by the WHO in 2007 [18] . Wasting was defined as weight for length Z-score ( 2 years old) or BMI Z-score (>2 years old) less than À2. Stunting was defined as height for age Z-score below À2. Moderate and severe wasting/stunting was defined as À3 Z-score < À2 and Z-score less than À3, respectively [19] . Low MUAC was defined as less than 11.5 cm for children under age 5 years, below 12.9 cm for children between age 5 and 9 years, and below 16.0 cm for children aged 10 years and above [20] . Elevated alanine aminotransferase (ALT) was defined as above 40 (U/l) for children aged 5 years or under [21] , above 30 (U/l) for children above 5 years [22] . For children age 5 years or below, immune suppression was defined none (CD4 þ % !25), advanced (15 CD4 þ % <25), or severe (CD4 þ %<15); for children above 5 years, immune suppression was defined none (CD4 þ cell count !500 cells/ml), advanced (200 cells/ml CD4 þ cell count <500 cells/ml), or severe (CD4 þ cell count <200 cells/ml) [23] . Anemia was measured by age-specific hemoglobin level: below 2 years, hemoglobin less than 9.5 g/dl; 2 to below 7 years, hemoglobin less than 11.0 g/dl; 7 to below 11 years, hemoglobin less than 11.5 g/dl; at least 11 years, hemoglobin less than 12.0 g/dl [24] .
Statistical methods
The Kaplan-Meier method was used to estimate the incidence of TB after enrollment [25] . The incidence was calculated from the date of enrollment in the program. Results are presented per 100 child-years of follow-up and 95% confidence intervals (CIs) were calculated using exact Poisson probabilities. The primary outcome was time to first TB diagnosis after enrollment. The Andersen-Gill formulation of the Cox proportional hazards model [26] was applied to evaluate the association between each characteristic measured at enrollment and selected time-varying parameters with the time to first TB diagnosis after enrollment. Children who did not experience incident TB were censored at death or loss to follow-up. A missing indicator was created when there were missing values [27] . Multivariate models were fit including all variables that were associated with the primary outcome with P less than 0.20 in the univariate analysis. The possibility of nonlinear relations between continuous covariates and the risk of incident TB was examined nonparametrically with restricted cubic splines [28] . All statistical tests were two-sided, with P less than 0.05 considered significant. All analyses were carried out using the statistical software package SAS, Release 9.2 (Cary, North Carolina, USA).
Results
There were 5040 HIV-infected children under age 15 years eligible for the analysis (Fig. 1 ). At enrollment, median age was 5 years and approximately one-half were male. The median length/height for age Z-score was À2.0 [interquartile range (IQR) À3.1 to À0.9]. The median MUAC was 15 (IQR 13-17) cm; 17% of children had low MUAC. Twenty-eight percent of patients were wasted at enrollment. For children 2 years old, the median weight for length Z-score was À1.1 (IQR À2.4 to À0.2), while for children older than 2 years, the median BMI Z-score was À1.0 (IQR À2.1 to À0.1). The median hemoglobin level was 9.9 (8.7-11.0) g/dl, and nearly three-quarters of children were anemic. Other characteristics at enrollment are presented in Table 1 .
During a median follow-up of 0.8 (IQR 0.1-2.5) years, 376 out of 5040 children met the case definition for tuberculosis. There were 7220.6 person-years of followup, with a corresponding incidence rate of 5.2 (95% CI 4.7-5.8) /100 person-years. The incidence rate was 15.0 (95% CI 12.7-17.7) /100 person-years in the first 3 months after enrollment, 7.0 (95% CI 5.8-8.5)/100 person-years during 3-6 months, and 2.3 (95% CI 1.9-2.7)/100 person-years after 6 months of follow-up. The median time to incident TB case from enrollment was 121 days (IQR 67-282 days). The associations between children's nutritional status at enrollment and risk of TB were explored. Three anthropometric indicators, weight-for-length/BMI Z-score, height-for-age Z-score, and MUAC, were separately examined in multivariate regression models. A similar pattern was noted for the three indicators: severe wasting was associated with a 1.8 times higher risk of TB than nonwasted children; severe stunting was associated with a 1.5 times higher risk, and low MUAC was associated with a 1.9 times higher risk ( Table 2) .
WHO HIV stage at enrollment, time-varying anemia and immune suppression were also significantly associated with the risk of TB (Table 2) . Compared with children who were stage I at enrollment, children who were stage II, III, and IV had 2.2, 4.2, and 4.5 times greater risk of developing TB, respectively (P-value for trend <0.001). Anemic children were 40% more likely to develop TB after controlling for other covariates. Figure 2 shows that the relative risk of TB decreased with an increase in CD4 þ % among children aged 5 years or under (P-value for linear relationship <0.001). A similar pattern can be seen in Fig. 3 , where higher CD4 þ cell count was associated with lower risk of TB among children above age 5 years (P-value for linear relationship 0.03). Children with severe immune suppression were at approximately three-fold higher risk of TB than children without significant immune suppression ( Table 2) .
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Discussion
Our study of HIV-infected children in Tanzania strongly supports the role of ART use in reducing the burden of tuberculosis, and also confirms the critical importance of nutritional status as predictors of TB risk, even after controlling for this ART effect and multiple other risk factors. Whether expressed as wasting, stunting or lower mid-upper arm circumference, nutritional deficits were associated with 1.5-1.9 times the risk of incident TB in our cohort.
Consistent with the previous literatures [6, 15, 29] , our study observed a protective relationship between ARTuse and the risk of childhood TB. We also demonstrated a further reduction in TB burden with longer duration of ART use. Studies among HIV-infected adults suggested that starting ART at higher CD4 cell counts (<350 cells/ml vs. <250 cells/ml) is an important public health strategy to reduce the risk of TB in resourcelimited settings [30] . Further study is needed to evaluate the same strategy among children. In our study, children who were initiated on EFV appeared to be at higher risk of TB than those who were initiated on NVP. EFV is recommended over NVP for older children, who may have been immune-compromised for a while and have stronger immune reconstitution after ART initiation. Host's enhanced immune reaction may itself cause more overt manifestations of some symptoms such as prolonged fever, respiratory symptoms and lymphadenopathy [31] , which makes these children more likely to be diagnosed with TB.
Our study also demonstrated that nutritional status is a strong predictor for the risk of TB among HIV-infected children. The relationship between undernutrition and TB could be bidirectional: having TB leads to undernutrition, and being undernourished is a risk factor for developing TB. In our analysis, we examined nutritional status at enrollment. Since children who had TB at enrollment and within 30 days after enrollment were excluded from the analysis, a temporal relationship between nutritional status and incident TB could be better established. We examined three indicators: stunting, wasting, and low MUAC separately and all were significantly associated with a higher risk of TB after controlling for the use of ART and several other risk factors. This suggests that both long-term and short-term malnutrition increases the risk of TB among HIVinfected children. However, this finding should be interpreted cautiously because of the possibility of TB immune reconstitution inflammatory syndrome (IRIS) secondarily leading to weight loss and malnutrition. In the MDH program, children with severe malnutrition are provided with ready to use therapeutic food. Nutritional rehabilitation could conceivably result in TB IRIS. Among adults, the triple burden of tuberculosis, HIV infection and malnutrition has been well documented [32] . More study is needed to assess the synergy of these diseases among children, as well as whether strategies to improve nutritional status reduce the risk of TB.
The risk of childhood TB decreased over the years of enrollment in this study, after controlling for other covariates. The reduction in childhood TB burden could be a reflection of Tanzanian success in TB control. Tanzania is one of the 22 high TB burden countries, which account for about 80% of all new cases each year and have been prioritized by WHO at global level since 2002 for TB control [33] . Today, the country has reached the target of halving the 1990 TB mortality rate by 2010, and TB incidence has decreased from 359/100 000 person-years in 2002 [33] to 177/100 000 person-years in 2011 nationwide [34] . ART initiation criteria for children under age 1 year old changed in 2007. Early ART initiation among this age group may also contribute to the decrease in the childhood TB incidence over years.
Children enrolled in the Kinondoni district had a higher risk of developing TB than children enrolled in other two districts. Compared with district Ilala, people in Kinondoni have lower social-economic status (SES) [35] which could lead to higher risk of TB. While based on Tanzania 2002 census [36] , the population density was much lower in Temeke (977 people/km 2 ) than in Kinondoni (2041 people/ km 2 ) and over-crowding may promote TB transmission [15] .
Our study identified several other risk factors for TB development among HIV-infected children. School attendance has been identified as a risk factor for childhood TB [15] which may contribute to the positive association between age and TB risk suggested by our study. Consistent with other published data [15, 37] , advanced immune suppression play a significant role as a risk factor for childhood TB. This suggests that establishing and maintaining virological suppression to maximize CD4 cell recovery is critical to reduce the risk of childhood TB. We found a strong association between anemia and the risk of childhood TB. One study conducted in Tanzania found that anemia with iron deficiency was associated with more than a six-fold increase in the risk of TB recurrence among HIV-infected adults [38] . One possible explanation for this finding is the iron redistribution known to occur in anemia of inflammation in HIV-infected patients [39] . Anemic children often receive iron supplements which may also contribute to developing of TB. The sequestration and loading of iron could facilitate replication of M. tuberculosis and inhibition of cellular defense systems [38] .
Our study documented a TB incidence rate of 5.2 (95% CI 4.7-5.8) /100 person-years after enrolling in an HIV care and treatment program. Previous studies in Africa reported an incidence rate among HIV-infected children of 0.8-21.1/100 person-years [15, 37, 40, 41] . This wide variation could reflect a true difference in childhood disease burden in different countries, or alternatively the variation could be due to the difficulty in making the diagnosis in children, use of different TB case definitions, as well as variable access to ART.
There are a number of limitations to this observational study. Information on viral load and detailed socioeconomic data were not routinely collected in this study. In addition, there was a moderate amount of missing data. To minimize the unintended consequences of missing data, we applied the missing indicator method in our analyses. Perhaps most importantly, we relied on the TB treatment recorded by the physician as our case definition of TB, as opposed to more standard microbiologic confirmation of infection. Despite these limitations, however, the strength of our study lies in its large sample size and relatively long follow-up period. The comprehensive clinical information collected from this cohort enabled us to identify important novel risk factors.
Our findings demonstrate that ART use and poor underlying nutritional status are important predictors for incident TB in HIV-infected children. TB screening should be focused on children with evidence of immunosuppression, malnutrition or anemia. Further studies are needed to elucidate the optimal timing of ART initiation and/or nutritional rehabilitation for these children to optimize health outcomes. Although major diagnostic and therapeutic challenges remain, given sufficient political commitment and well designed interventions, the management of HIV-infected children at risk of TB can be substantially improved.
